Parschauer Karah Herdman's Form 4 filing
Ultragenyx Pharmaceutical Inc. (RARE) · filed Jun 15, 2026
- Accession no.
- 0001677455-26-000002
- Filed
- Jun 15, 2026
- Trade date
- Jun 15, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $46.8K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parschauer Karah HerdmanCIK 0001677455 | Officer (EVP and Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | SSaleDisposed | −1,899 | $24.62 | −$46,753.38 | 94,462 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.